Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024 Jun 22, 2024
Research identifies optimal body weight to reduce cardiovascular risk in diabetes patients Mar 31, 2024
COVID-19 vaccine associated with reduced risk of cardiac and clot-related complications after SARS-CoV-2 infection Mar 18, 2024
HartWacht app enables remote blood pressure and arrhythmia monitoring for Amsterdam UMC patients Feb 15, 2024